Effectiveness of Aripiprazole Long-acting Injection in Recent Onset and Chronic Schizophrenia Patients

C

Chonbuk National University

Status and phase

Completed
Phase 4

Conditions

Schizophrenia

Treatments

Drug: abilify maintena

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT03839251
CUH 2018-02-011-005

Details and patient eligibility

About

The aim of the study is to investigate the effectiveness of Aripiprazole long-acting injection in recent onset and chronic schizophrenia patients

Full description

The aim of this study is to investigate the effectiveness of Aripiprazole long-acting injection in recent onset and chronic schizophrenia patients

Enrollment

82 patients

Sex

All

Ages

19 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients diagnosed with schizophrenia according to DSM-5 diagnostic standards
  • men and women aged 19 and under 60
  • a person who is being given an atypical antipsychotic.
  • Patients should be able to reasonably cooperate with the questionnaire to be used for the study
  • a person who fully understands the purpose of the study and signs the consent
  • stable outpatient before screening without changing the volume of antipsychotics for at least two weeks

Exclusion criteria

  • a person who has a serious and unstable physical condition either now or in the past
  • A fertile woman who is currently pregnant or breastfeeding, or who is either unwilling or unable to use acceptable contraception until the clinical trial is complete.
  • a person suffering from severe drug allergies or complex and severe drug reactions
  • Patients who have taken clozapine in the last 60 days
  • subjects showing significant risk of suicide or significant risk of violent behavior based on past history or investigator's judgment

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

82 participants in 1 patient group

abilify maintena
Other group
Description:
aripiprazole 400mg or 300mg, IM, Once a month
Treatment:
Drug: abilify maintena

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems